TrialBreast cancer research and treatment2016

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study.

M E Cazzaniga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.